Corrigendum: Prediction of Mortality in Adolescents with Cystic Fibrosis (Medicine and Science in Sports and Exercise (2014) 46:11 (2047-2052) DOI: 10.1249/MSS.0000000000000344);Prediction of mortality in adolescents with cystic fibrosis

Medicine and Science in Sports and Exercise

Volumn 46, Issue 11, 2014, Pages 2047-2052

  Hulzebos, Erik H J ^a   Bomhof Roordink, Hanna ^a,b   Van De Weert Van Leeuwen, Pauline B ^a   Twisk, Jos W R ^b   Arets, H G M ^a   Van Der Ent, Cornelis K ^a   Takken, Tim ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cystic fibrosis; Exercise capacity; Lung function; Mortality; Nutritional status

Indexed keywords

ADOLESCENT; BODY MASS; CHILD; CYSTIC FIBROSIS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG; MALE; MORTALITY; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

ADOLESCENT; BODY MASS INDEX; CHILD; CYSTIC FIBROSIS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 84916879291     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000001557     Document Type: Erratum

References (44)

1. Belkin RA, Henig NR, Singer LG, et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med. 2006;173(6):659-66.
2. Bongers BC, Hulzebos EH, Arets BG, Takken T. Validity of the oxygen uptake efficiency slope in children with cystic fibrosis andmildto- moderate airflow obstruction. Pediatr Exerc Sci. 2012;24(1):129-41.
3. Bradley J, Moran F. Physical training for cystic fibrosis. Cochrane Database Syst Rev. 2002;(2):CD002768.
4. Buzzetti R, Alicandro G, Minicucci L, et al. Validation of a predictive survival model in Italian patients with cystic fibrosis. J Cyst Fibros. 2012;11(1):24-9.
5. Chamnan P, Shine BS, Haworth CS, Bilton D, Adler AI. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care. 2010;33(2):311-6.
6. Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr. 1997;131(6):809-14.
7. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583-91.
8. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29(3):522-6.
9. Cox DR. Regression model and life-tables J Roy Statist Soc Ser B Metho. 1972;34(2):187-220.
10. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993;122(1):1-9.
11. Fogarty AW, Britton J, Clayton A, Smyth AR. Are measures of body habitus associated with mortality in cystic fibrosis? Chest. 2012;142(3):712-7.
12. Godfrey S. Exercise testing in assessing children with lung or heart disease. Thorax. 1970;25(2):258.
13. Hebestreit H, Kieser S, Rüdiger S, et al. Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J. 2006;28(4):734-9.
14. Huang NN, Schidlow DV, Szatrowski TH, et al. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med. 1987;82(5):871-9.
15. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187-91.
16. Klijn PH, Oudshoorn A, van der Ent CK, van der NJ, Kimpen JL, Helders PJ. Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest. 2004;125(4):1299-305.
17. Konstan MW, Wagener JS, Vandevanter DR, et al. Risk factors for rate of decline in FEV1 in adults with cystic fibrosis. J Cyst Fibros. 2012;11(5):405-11.
18. Koopman M, Zanen P, Kruitwagen CL, van der Ent CK, Arets HG. Reference values for paediatric pulmonary function testing: the Utrecht dataset. Respir Med. 2011;105(1):15-23.
19. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153(4):345-52.
20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-38.
21. Moorcroft AJ, Dodd ME, Webb AK. Exercise testing and prognosis in adult cystic fibrosis. Thorax. 1997;52(3):291-3.
22. Moorcroft AJ, Dodd ME, Webb AK. Long-term change in exercise capacity, body mass, and pulmonary function in adults with cystic fibrosis. Chest. 1997;111(2):338-43.
23. Morton AM. Symposium 6: young people, artificial nutrition and transitional care. The nutritional challenges of the young adult with cystic fibrosis: transition. Proc Nutr Soc. 2009;68(4):430-40.
24. Nguyen T, Obeid J, Baker JM, et al. Reduced fat oxidation rates during submaximal exercise in boys with cystic fibrosis. J Cyst Fibros. 2014;13(1):92-8.
25. Nixon PA, Orenstein DM. Exercise testing in children. Pediatr Pulmonol. 1988;5:107-22.
26. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992;327(25):1785-8.
27. Orenstein DM, Franklin BA, Doershuk CF, et al. Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three-month supervised running program. Chest. 1981; 80(4):392-8.
28. Pianosi P, Leblanc J, Almudevar A. Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax. 2005; 60(1):50-4.
29. Powers SW, Jones JS, Ferguson KS, Piazza-Waggoner C, Daines C, Acton JD. Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis. Pediatrics. 2005; 116(6):1442-50.
30. Rasmussen B, Klausen K, Clausen JP, Trap-Jensen J. Pulmonary ventilation, blood gases, and blood pH after training of the arms or the legs. J Appl Physiol. 1975;38(2):250-6.
31. Sharma R, Florea VG, Bolger AP, et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax. 2001;56(10):746-50.
32. Sharples L, Hathaway T, Dennis C, Caine N, Higenbottam T, Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant. 1993; 12(4):669-74.
33. Simmonds NJ, Macneill SJ, Cullinan P, Hodson ME. Cystic fibrosis and survival to 40 years: a case-control study. Eur Respir J. 2010;36(6):1277-83.
34. Slieker MG, Uiterwaal CS, Sinaasappel M, Heijerman HG, van der Laag J, van der Ent CK. Birth prevalence and survival in cystic fibrosis: a national cohort study in the Netherlands. Chest. 2005; 128(4):2309-15.
35. Snell GI, Bennetts K, Bartolo J, et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant. 1998;17(11):1097-103.
36. Stanghelle JK, Skyberg D, Haanaes OC. Eight-year follow-up of pulmonary function and oxygen uptake during exercise in 16-yearold males with cystic fibrosis. Acta Paediatr. 1992;81(6-7):527-31.
37. Stein R, Selvadurai H, Coates A, Wilkes DL, Schneiderman-Walker J, Corey M. Determination of maximal voluntary ventilation in children with cystic fibrosis. Pediatr Pulmonol. 2003; 35(6):467-71.
38. Tantisira KG, Systrom DM, Ginns LC. An elevated breathing reserve index at the lactate threshold is a predictor of mortality in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med. 2002;165(12):1629-33.
39. Ten Harkel AD, Takken T. Normal values for cardiopulmonary exercise testing in children. Eur J Cardiovasc Prev Rehabil. 2011; 18(4):676-7.
40. Van de Weert-van Leeuwen PB, Slieker MG, Hulzebos HJ, Kruitwagen CL, van der Ent CK, Arets HG. Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur Respir J. 2012;39(4):893-8.
41. van Doorn N. Exercise programs for children with cystic fibrosis: a systematic review of randomized controlled trials. Disabil Rehabil. 2010;32(1):41-9.
42. Vieni G, Faraci S, Collura M, et al. Stunting is an independent predictor of mortality in patients with cystic fibrosis. Clin Nutr. 2013;32(3):382-5.
43. Winkelmann ER, Chiappa GR, Lima CO, Viecili PR, Stein R, Ribeiro JP. Addition of inspiratory muscle training to aerobic training improves cardiorespiratory responses to exercise in patients with heart failure and inspiratory muscle weakness. Am Heart J. 2009;158(5):768-7.
44. Zapletal A, Samenek TP. Lung function in children and adolescents: methods and reference values. Cesk Pediatr. 1976; 31(10):532-9.